Lonza, Akouos and MEE Announce Strategic Gene Therapy License Agreements on Hearing and Balance Disorders

News   Dec 03, 2017

 
Lonza, Akouos and MEE Announce Strategic Gene Therapy License Agreements on Hearing and Balance Disorders
 
 
 

RELATED ARTICLES

Progressive Kidney Disease: New Compound Restores Kidney Function

News

A team led by researchers describe a new approach to prevent death in these essential kidney cells. Studying multiple animal models of kidney disease, the team discovered a compound that can impede loss of the filtration cells and restore kidney function.

READ MORE

Targeted Antisense Treatment of APOE4 Reduces Alzheimer's Damage

News

Novel antisense oligonucleotide interferes with the instructions for building the APOE protein and reduces pathophysiology of AD.

READ MORE

Zika Vaccine Trials Provide Promising Results

News

Researchers report that an investigational Zika vaccine was well-tolerated and stimulated potentially protective immune responses in three Phase 1 clinical trials,

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE